Upstream Bio, Inc. (UPB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $152.38M
Last updated: Nov 17, 2026 at 11:05 AM ET
Upstream Bio, Inc. (UPB) Earnings: Report Dates and Results
Upstream Bio (UPB) is expected to report earnings on Mar 24, 2027. In the quarter ended Sep 30, 2026, Upstream Bio reported EPS of -$0.75, below the -$0.67 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
UPB has an expected report date of Mar 24, 2027.
Earnings History
Of the 9 quarters below that had an estimate, UPB beat 3, missed 5 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $395000, down 42.2% from $683000 a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.75 | -$0.67 | -$0.88 - -$0.52 | -11.94% | Miss | N/A | 8 | 4 up, 3 down | Nov 10, 2026 | $395000 |
| Jun 30, 2026 | -$0.73 | -$0.78 | -$0.87 - -$0.62 | +6.41% | Beat | N/A | 9 | 2 up, 5 down | Aug 11, 2026 | $773000 |
| Mar 31, 2026 | -$0.75 | -$0.75 | -$0.89 - -$0.64 | 0.00% | In line | N/A | 8 | 1 up, 2 down | May 13, 2026 | $1.03M |
| Dec 31, 2025 | -$0.78 | -$0.70 | -$0.70 - -$0.65 | -11.43% | Miss | N/A | 3 | 1 up, 0 down | Mar 26, 2026 | $668000 |
| Sep 30, 2025 | -$0.63 | -$0.78 | -$0.85 - -$0.67 | +19.23% | Beat | N/A | 5 | 1 up, 2 down | Nov 5, 2025 | $683000 |
| Jun 30, 2025 | -$0.74 | -$0.61 | N/A | -21.31% | Miss | N/A | N/A | N/A | Aug 6, 2025 | $937000 |
| Mar 31, 2025 | -$0.51 | -$0.48 | -$0.59 - -$0.40 | -6.25% | Miss | N/A | 4 | 0 up, 0 down | May 6, 2025 | $566000 |
| Dec 31, 2024 | -$0.41 | -$0.54 | -$0.77 - -$0.39 | +24.12% | Beat | N/A | 4 | N/A | Mar 13, 2025 | $613000 |
| Sep 30, 2024 | -$6.96 | -$3.65 | N/A | -90.68% | Miss | N/A | N/A | N/A | Oct 11, 2024 | $607000 |
| Jun 30, 2024 | -$11.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 28, 2024 | $510000 |
Annual EPS
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | -$2.23 | N/A |
| Jun 30, 2026 | -$1.48 | N/A |
| Dec 31, 2025 | -$2.66 | N/A |
| Dec 31, 2024 | -$18.55 | N/A |
Frequently Asked Questions About UPB
When is Upstream Bio's next earnings date?
Upstream Bio's next earnings report is expected for Mar 24, 2027.
Did UPB beat earnings estimates last quarter?
No. Upstream Bio reported EPS of -$0.75 for the quarter ended Sep 30, 2026, below the -$0.67 estimate by 11.94%.
What EPS do analysts expect from UPB next quarter?
The consensus EPS estimate for Upstream Bio for the quarter ending Dec 31, 2026 is -$0.72 from 8 analysts, with estimates from -$0.93 to -$0.44.
How often does UPB beat earnings estimates?
Upstream Bio beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -0.15%.
UPB pages: Overview, Earnings, Forecast, Financials, Competitors